Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Oct;32(4):238-41.
doi: 10.4103/0971-5851.95150.

Neonatal Kasabach-Merritt phenomenon

Dinesh Yadav  1 , Anu Maheshwari, Satinder Aneja, Anju Seth, Jagdish Chandra
Affiliations
Case Reports

Neonatal Kasabach-Merritt phenomenon

Dinesh Yadav et al. Indian J Med Paediatr Oncol. 2011 Oct.

Abstract

Kasabach-Merritt phenomenon (KMP) is a life-threatening consumptive coagulopathy in the presence of a rapidly enlarging vascular tumor. It usually presents in early infancy, but onset in early neonatal period, facial hemangioma, and vincristine use in neonates has rarely been reported. We, hereby, present a 6-day-old male child presenting with facial hemangioma and intracranial hemorrhage, and KMP responding well to steroids and vincristine. Pathophysiology of disease and various treatment options have been discussed.

Keywords: Kasabach-Merritt phenomenon; neonate; vincristine.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
At presentation. Hemangioma involving right half of face and earlobe
Figure 2
Figure 2
After 3 month of therapy. Significant reduction in size of tumor
See this image and copyright information in PMC

References

    1. Kelly M. Kasabach-Merritt Phenomenon. Pediatr Clin North Am. 2010;57:1085–9. - PubMed
    1. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: Report of a case. Am J Dis Child. 1940;59:1063–70.
    1. Haisley-Royster C, Enjolras O, Frieden IJ, Garzon M, Lee M, Oranje A, et al. Kasabach-Merritt phenomenon: A retrospective study of treatment with vincristine. J Pediatr Hematol Oncol. 2002;24:459–62. - PubMed
    1. Shin HY, Ryu KH, Ahn HS. Stepwise multimodal approach in the treatment of Kasabach–Merritt syndrome. Pediatr Int. 2000;42:620–4. - PubMed
    1. Wananukul S, Nuchprayoon I, Seksarn P. Treatment of Kasabach–Merritt syndrome: A stepwise regimen of prednisolone, dipyridamole, and interferon. Int J Dermatol. 2003;42:741–8. - PubMed

Publication types

LinkOut - more resources